Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Definitive radiotherapy vs. postoperative radiotherapy for lower gingival carcinomas of the mandible : A single-center report about outcome and toxicity.

Lang K, Akbaba S, Held T, Kargus S, Horn D, Bougatf N, Bernhardt D, Freier K, Rieken S, Debus J, Adeberg S.

Strahlenther Onkol. 2019 Jul 2. doi: 10.1007/s00066-019-01484-z. [Epub ahead of print]

PMID:
31267170
2.

Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients-First Clinical Results From a Single Center.

König L, Lang K, Heil J, Golatta M, Major G, Krug D, Hörner-Rieber J, Häfner MF, Koerber SA, Harrabi S, Bostel T, Debus J, Uhl M.

Front Oncol. 2019 May 21;9:384. doi: 10.3389/fonc.2019.00384. eCollection 2019.

3.

Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.

Akbaba S, Ahmed D, Lang K, Held T, Mattke M, Hoerner-Rieber J, Herfarth K, Rieken S, Plinkert P, Debus J, Adeberg S.

Oral Oncol. 2019 Apr;91:39-46. doi: 10.1016/j.oraloncology.2019.02.019. Epub 2019 Feb 27.

PMID:
30926061
4.

Clinical Management of Blood⁻Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer.

Held T, Akbaba S, Lang K, Harrabi S, Bernhardt D, Freudlsperger C, Kargus S, Plinkert P, Rieken S, Herfarth K, Debus J, Adeberg S.

Cancers (Basel). 2019 Mar 19;11(3). pii: E383. doi: 10.3390/cancers11030383.

5.

Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control.

Akbaba S, Held T, Lang K, Forster T, Federspil P, Herfarth K, Häfner M, Plinkert P, Rieken S, Debus J, Adeberg S.

Cancers (Basel). 2019 Mar 17;11(3). pii: E379. doi: 10.3390/cancers11030379.

6.

Pre-Operative Versus Post-Operative Radiosurgery of Brain Metastases-Volumetric and Dosimetric Impact of Treatment Sequence and Margin Concept.

El Shafie RA, Tonndorf-Martini E, Schmitt D, Weber D, Celik A, Dresel T, Bernhardt D, Lang K, Hoegen P, Adeberg S, Paul A, Debus J, Rieken S.

Cancers (Basel). 2019 Mar 1;11(3). pii: E294. doi: 10.3390/cancers11030294.

7.

Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.

Akbaba S, Held T, Lang K, Hoerner-Rieber J, Zaoui K, Forster T, Rieken S, Plinkert P, Debus J, Adeberg S.

Radiat Oncol. 2019 Feb 19;14(1):34. doi: 10.1186/s13014-019-1238-8.

8.

Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety.

Akbaba S, Lang K, Held T, Herfarth K, Rieber J, Plinkert P, Auffarth GU, Rieken S, Debus J, Adeberg S.

Cancer Manag Res. 2019 Feb 1;11:1155-1166. doi: 10.2147/CMAR.S190051. eCollection 2019.

9.

The role of organ- and function-preserving radiotherapy in the treatment of adenoid cystic carcinoma of the larynx.

Akbaba S, Lang K, Bulut OC, Held T, Rieken S, Plinkert P, Jensen A, Herfarth K, Debus J, Adeberg S.

Head Neck. 2019 Jul;41(7):2208-2214. doi: 10.1002/hed.25678. Epub 2019 Feb 5.

PMID:
30723979
10.

Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis.

El Shafie RA, Böhm K, Weber D, Lang K, Schlaich F, Adeberg S, Paul A, Haefner MF, Katayama S, Sterzing F, Hörner-Rieber J, Löw S, Herfarth K, Debus J, Rieken S, Bernhardt D.

Cancer Manag Res. 2019 Jan 17;11:789-801. doi: 10.2147/CMAR.S182154. eCollection 2019.

11.

Palliative Radiotherapy for Leptomeningeal Carcinomatosis-Analysis of Outcome, Prognostic Factors, and Symptom Response.

El Shafie RA, Böhm K, Weber D, Lang K, Schlaich F, Adeberg S, Paul A, Haefner MF, Katayama S, Hörner-Rieber J, Hoegen P, Löw S, Debus J, Rieken S, Bernhardt D.

Front Oncol. 2019 Jan 8;8:641. doi: 10.3389/fonc.2018.00641. eCollection 2018.

12.

Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity.

Lang K, Baur M, Akbaba S, Held T, Kargus S, Bougatf N, Bernhardt D, Freier K, Plinkert PK, Rieken S, Debus J, Adeberg S.

Cancers (Basel). 2018 Dec 4;10(12). pii: E488. doi: 10.3390/cancers10120488.

13.

Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety.

Akbaba S, Lang K, Held T, Bulut OC, Mattke M, Uhl M, Jensen A, Plinkert P, Rieken S, Herfarth K, Debus J, Adeberg S.

Cancers (Basel). 2018 Oct 18;10(10). pii: E388. doi: 10.3390/cancers10100388.

14.

Robotic Radiosurgery for Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence (CYBER-SPACE)-A Single-Center Prospective Randomized Trial.

El Shafie RA, Paul A, Bernhardt D, Lang K, Welzel T, Sprave T, Hommertgen A, Krisam J, Schmitt D, Klüter S, Schubert K, Klose C, Kieser M, Debus J, Rieken S.

Neurosurgery. 2019 Jan 1;84(1):253-260. doi: 10.1093/neuros/nyy026.

PMID:
29554321
15.

Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.

Bernhardt D, König L, Aufderstrasse S, Krisam J, Hoerner-Rieber J, Adeberg S, Bozorgmehr F, El Shafie R, Lang K, Kappes J, Thomas M, Herth F, Heußel CP, Warth A, Marcrom S, Debus J, Steins M, Rieken S.

Clin Lung Cancer. 2018 Jul;19(4):340-345. doi: 10.1016/j.cllc.2017.12.004. Epub 2017 Dec 15.

PMID:
29373273
16.

Stability of Spinal Bone Lesions in Patients With Multiple Myeloma After Radiotherapy-A Retrospective Analysis of 130 Cases.

Lang K, König L, Bruckner T, Förster R, Sprave T, Schlampp I, Bostel T, Welte S, Nicolay NH, Debus J, Rief H.

Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e99-e107. doi: 10.1016/j.clml.2017.09.005. Epub 2017 Sep 19.

PMID:
28993162
17.

Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.

Haefner MF, Lang K, Verma V, Koerber SA, Uhlmann L, Debus J, Sterzing F.

Strahlenther Onkol. 2018 Feb;194(2):116-124. doi: 10.1007/s00066-017-1211-0. Epub 2017 Sep 15.

PMID:
28916906
18.

Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.

Haefner MF, Lang K, Verma V, Koerber SA, Uhlmann L, Debus J, Sterzing F.

Radiat Oncol. 2017 Aug 15;12(1):131. doi: 10.1186/s13014-017-0863-3.

19.

Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.

Haefner MF, Lang K, Krug D, Koerber SA, Uhlmann L, Kieser M, Debus J, Sterzing F.

J Radiat Res. 2015 Jul;56(4):742-9. doi: 10.1093/jrr/rrv022. Epub 2015 Apr 23.

20.

Mutation in exon 1a of PLEC, leading to disruption of plectin isoform 1a, causes autosomal-recessive skin-only epidermolysis bullosa simplex.

Gostyńska KB, Nijenhuis M, Lemmink H, Pas HH, Pasmooij AM, Lang KK, Castañón MJ, Wiche G, Jonkman MF.

Hum Mol Genet. 2015 Jun 1;24(11):3155-62. doi: 10.1093/hmg/ddv066. Epub 2015 Feb 24.

PMID:
25712130

Supplemental Content

Loading ...
Support Center